巴西统一公共卫生系统中药物洗脱支架在经皮冠状动脉介入治疗中的成本效益数据集

数据集获取（Figshare）

• 源站标题：Cost-effectiveness of Drug-Eluting Stents in Percutaneous Coronary Intervention in Brazil’s Unified Public Health System (SUS)
• DOI：10.6084/m9.figshare.14277706.v1
• 发布日期：2021-03-24
• 文件数：7 个
• 文件总体积：205.88 KB
• 源站页面：https://scielo.figshare.com/articles/dataset/Cost-effectiveness_of_Drug-Eluting_Stents_in_Percutaneous_Coronary_Intervention_in_Brazil_s_Unified_Public_Health_System_SUS_/14277706

命令行下载

curl -L -o "0066-782X-abc-115-01-0080-gf01-en.jpg" "https://ndownloader.figshare.com/files/27091777"
curl -L -o "0066-782X-abc-115-01-0080-gf02-en.jpg" "https://ndownloader.figshare.com/files/27091780"
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/27091783"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/27091786"
curl -L -o "Table_3.xls" "https://ndownloader.figshare.com/files/27091789"
curl -L -o "Table_4.xls" "https://ndownloader.figshare.com/files/27091792"
curl -L -o "Table_5.xls" "https://ndownloader.figshare.com/files/27091795"

文件清单

• 0066-782X-abc-115-01-0080-gf01-en.jpg（72.57 KB）
• 0066-782X-abc-115-01-0080-gf02-en.jpg（92.86 KB）
• Table_1.xls（9.73 KB）
• Table_2.xls（5.63 KB）
• Table_3.xls（9.73 KB）
• Table_4.xls（5.63 KB）
• Table_5.xls（9.73 KB）

文件总体积 205.88 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Abstract Background The use of drug-eluting stents (DESs), compared with bare-metal stents (BMSs), in percutaneous coronary intervention (PCI) has reduced the rate of restenosis, without an impact on mortality but with an increase in costs. Medical literature lacks randomized studies that economically compare these 2 stent types within the reality of the Brazilian Unified Public Health System (SUS). Objective To estimate the incremental cost-effectiveness ratio (ICER) between DES and BMS in SUS patients with single-vessel coronary artery disease. Methods Over a 3-year period, patients with symptomatic single-vessel coronary artery disease were randomized in a 1:2 ratio to receive a DES or BMS during PCI, with a 1-year clinical follow-up. The evaluation included in-stent restenosis (ISR), target lesion revascularization (TLR), major adverse events, and cost-effectiveness for each group. P-values

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.14277706.v1（source: https://scielo.figshare.com/articles/dataset/Cost-effectiveness_of_Drug-Eluting_Stents_in_Percutaneous_Coronary_Intervention_in_Brazil_s_Unified_Public_Health_System_SUS_/14277706）。